<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28126" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pyruvate Kinase Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Enegela</surname>
            <given-names>Ogboche A.</given-names>
          </name>
          <aff>University Hospitals Coventry and Warwickshire</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ogboche Enegela declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28126.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pyruvate kinase deficiency (PKD) is the most common enzyme-related glycolytic defect that results in red cell hemolysis. Invariably, PKD results in hereditary non-spherocytic anemia. This activity reviews the evaluation and management of pyruvate kinase deficiency and highlights the role of the healthcare team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the etiology of pyruvate kinase deficiency.</p></list-item><list-item><p>Describe the appropriate evaluation of patients with pyruvate kinase deficiency.</p></list-item><list-item><p>Outline the management options available for pyruvate kinase deficiency.</p></list-item><list-item><p>Summarize the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients affected by pyruvate kinase deficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28126">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28126.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pyruvate kinase deficiency (PKD)&#x000a0;is the most common enzyme-related glycolytic defect that results in red cell hemolysis.<xref ref-type="bibr" rid="article-28126.r1">[1]</xref><xref ref-type="bibr" rid="article-28126.r2">[2]</xref><xref ref-type="bibr" rid="article-28126.r3">[3]</xref><xref ref-type="bibr" rid="article-28126.r4">[4]</xref><xref ref-type="bibr" rid="article-28126.r5">[5]</xref> This disorder is characterized by clinical heterogeneity.<xref ref-type="bibr" rid="article-28126.r5">[5]</xref><xref ref-type="bibr" rid="article-28126.r6">[6]</xref>&#x000a0;Heterogeneity results in a variable degree of hemolysis, causing irreversible cellular disruption.<xref ref-type="bibr" rid="article-28126.r6">[6]</xref><xref ref-type="bibr" rid="article-28126.r7">[7]</xref><xref ref-type="bibr" rid="article-28126.r8">[8]</xref>&#x000a0;Invariably, PKD results in hereditary non-spherocytic anemia.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref><xref ref-type="bibr" rid="article-28126.r10">[10]</xref> Manifestations occur from the neonatal period through adult life.<xref ref-type="bibr" rid="article-28126.r10">[10]</xref>&#x000a0;A myriad of complications could arise from hemolytic anemia.<xref ref-type="bibr" rid="article-28126.r1">[1]</xref><xref ref-type="bibr" rid="article-28126.r9">[9]</xref></p>
      </sec>
      <sec id="article-28126.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Red blood cell (RBC) metabolism hinges on glycolysis. Pyruvate kinase (PK) enzyme is key to this process. PK converts phosphoenolpyruvate to pyruvate.<xref ref-type="bibr" rid="article-28126.r2">[2]</xref> This step yields 50% of RBC ATP. PK modulates NADH production for methemoglobin reduction.<xref ref-type="bibr" rid="article-28126.r11">[11]</xref><bold>&#x000a0;</bold>These metabolites enable RBCs to function effectively. In PKD, cellular energy efficiency and longevity decrease. Young RBCs are most affected in PKD.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;PK expression is controlled by the PK-LR gene. The gene is located on chromosome 1q21.<xref ref-type="bibr" rid="article-28126.r3">[3]</xref> PKD follows an autosomal recessive inheritance pattern.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;Homozygotes and compound heterozygotes are affected. Compound heterozygotes inherit two different mutant alleles.<xref ref-type="bibr" rid="article-28126.r12">[12]</xref>&#x000a0;About 300 PKD-causing mutations have been found.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref>&#x000a0;The majority of these are missense mutations.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref><xref ref-type="bibr" rid="article-28126.r13">[13]</xref>&#x000a0;However, novel mutations have been reported.<xref ref-type="bibr" rid="article-28126.r14">[14]</xref><xref ref-type="bibr" rid="article-28126.r15">[15]</xref><bold>&#x000a0;</bold>Frameshift, deletion, and insertion type mutations can occur.<xref ref-type="bibr" rid="article-28126.r16">[16]</xref></p>
      </sec>
      <sec id="article-28126.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PKD was first discovered in 1961 by Valentine et al.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Since this discovery, worldwide reports have emerged. PKD is a rare disorder. The true prevalence of PKD is unknown.<xref ref-type="bibr" rid="article-28126.r4">[4]</xref>&#x000a0;Estimated PKD prevalence ranges from 3.2 - 8.5 cases per million of the Western population.<xref ref-type="bibr" rid="article-28126.r10">[10]</xref>&#x000a0;However, a prevalence of 1:20,000 has been reported.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><xref ref-type="bibr" rid="article-28126.r17">[17]</xref>&#x000a0;Mutant allele frequency may approach 51 per million.<xref ref-type="bibr" rid="article-28126.r6">[6]</xref>&#x000a0;Case clusters&#x000a0;are found in Brazil and Tunisia.<xref ref-type="bibr" rid="article-28126.r6">[6]</xref><xref ref-type="bibr" rid="article-28126.r7">[7]</xref>&#x000a0;</p>
        <p>Evidence of PKD-related gender differences appears scarce.&#x000a0;Specific mutations have higher frequencies in certain communities, such as Pennsylvania Amish and Romani communities.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;Certain factors could explain this finding. A founder effect indicates the heritability of mutations. Mutations have been traced to specific migrant couples. In addition, consanguinity increases the risk of homozygosity.<xref ref-type="bibr" rid="article-28126.r17">[17]</xref></p>
      </sec>
      <sec id="article-28126.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cellular integrity of RBCs is maintained by membrane-bound ATPases. ATPases exchange sodium for potassium. This maintains transcellular electrochemical neutrality, cellular fluid balance, and deformability.<xref ref-type="bibr" rid="article-28126.r8">[8]</xref>&#x000a0;Lack of PK enzyme decreases RBC ATP production, causing decreased RBC deformability. Intracellular potassium and water loss also occur.<xref ref-type="bibr" rid="article-28126.r18">[18]</xref>&#x000a0;This results in RBC damage. PKD manifests with enzyme levels of &#x0003c;25%.<xref ref-type="bibr" rid="article-28126.r19">[19]</xref>&#x000a0;Splenic and hepatic capillaries trap defective RBCs. Extravascular hemolysis occurs, causing hepatosplenomegaly. Intravascular hemolysis may also occur, causing hemoglobinuria.<xref ref-type="bibr" rid="article-28126.r3">[3]</xref>&#x000a0;Anemia underlies the progressive fatigue in PKD. Increased 2,3-diphosphoglycerate (2,3-DPG) causes oxygen unloading in tissues. This shifts the oxygen dissociation curve rightward.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;Elevated 2,3-DPG helps compensate for anemia. These mechanisms play out in homozygotic patients. Heterozygote carriers are usually asymptomatic. However, hemolysis may occur in stressful conditions. Chronic hemolysis results in folate deficiency. Extramedullary hemopoiesis has been reported in PKD.&#x000a0;</p>
        <p>Neonatal RBCs consume more ATP than in adults.<xref ref-type="bibr" rid="article-28126.r16">[16]</xref>&#x000a0;Splenic destruction of reticulocytes causes hyperbilirubinemia, and exchange transfusion to prevent kernicterus may be required. Severe anemia in-utero can result in fetal hydrops. Transfusion-dependent neonatal anemia may occur.<xref ref-type="bibr" rid="article-28126.r1">[1]</xref><xref ref-type="bibr" rid="article-28126.r20">[20]</xref></p>
        <p>Dilutional anemia occurs in the second trimester of pregnancy in these patients. Plasma volume increases more than RBC mass.<xref ref-type="bibr" rid="article-28126.r21">[21]</xref>&#x000a0;Maternal hemodilution presumably improves fetal outcomes. It also minimizes postpartum blood loss.<xref ref-type="bibr" rid="article-28126.r22">[22]</xref>&#x000a0;PKD may exacerbate physiologic anemia of pregnancy.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref><xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Episodic hemolysis may require RBC transfusion replacement.</p>
      </sec>
      <sec id="article-28126.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Neonates</bold>
</p>
        <p>Manifestations include hyperbilirubinemia and anemia. Surviving neonates have recognizable pallor.<xref ref-type="bibr" rid="article-28126.r23">[23]</xref>&#x000a0;Characteristic worsening pallor in the first week occurs. Poor suckling with frequent pauses may occur. Lethargy and poor weight gain may manifest.&#x000a0;Tachypnea may indicate heart failure. Hydrops may develop in-utero. Skin edema and birth asphyxia are common. Stillbirth frequently complicates hydrops.<xref ref-type="bibr" rid="article-28126.r24">[24]</xref> Blueberry muffin rashes indicating extramedullary hemopoiesis may occur in these newborns.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref>&#x000a0;Yellow skin and sclerae manifest jaundice. Kernicterus may supervene with severe untreated hemolysis.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref><xref ref-type="bibr" rid="article-28126.r17">[17]</xref>&#x000a0;</p>
        <p>
<bold>Older Children and Adults</bold>
</p>
        <p>Older children may present with poor growth, easy fatiguability, and jaundice. Some&#x000a0;children may&#x000a0;have poor appetite and dizziness.<xref ref-type="bibr" rid="article-28126.r17">[17]</xref>&#x000a0;Stress may precipitate hemolytic crises. Physical examination shows icterus and conjunctival pallor. Hepatosplenomegaly due to hemolysis occurs. Extramedullary hemopoiesis may result in frontal bossing.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Adults may present with complications. These include gall stones, hemosiderosis, and aplastic anemia.</p>
      </sec>
      <sec id="article-28126.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory evaluation is indicated for neonatal anemia or hyperbilirubinemia. Childhood chronic anemia with splenomegaly warrants investigation. Transfusion-dependent patients require evaluation.<xref ref-type="bibr" rid="article-28126.r4">[4]</xref><bold>&#x000a0;</bold>Complete blood count characterizes anemia.&#x000a0;Hemoglobin levels vary for different severities of PK deficiency. A blood smear shows normochromic cells. Polychromasia with echinocytes may be seen. Spherocytes are absent.&#x000a0;Macrocytosis indicates folate deficiency.<xref ref-type="bibr" rid="article-28126.r3">[3]</xref>&#x000a0;Reticulocytosis does not correlate with hemolysis.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;LDH is elevated, and haptoglobin is low.&#x000a0;Coombs' test and osmotic fragility are negative. Hemoglobin electrophoresis is normal.</p>
        <p>PK activity level is key to the diagnosis. PKD suspicion is warranted with near-normal PK levels. In these cases, adjusted measures are necessary. RBC age-corrected PK enzyme levels are low. Pyruvate kinase/hexokinase activity ratio is also low.<xref ref-type="bibr" rid="article-28126.r4">[4]</xref></p>
        <p>Genetic analysis showing PKLR mutations is diagnostic. Mutation types are elucidated by this method.&#x000a0;</p>
        <p>Iron overload is a risk in PKD. Regular screening with iron studies may reveal its onset.<xref ref-type="bibr" rid="article-28126.r25">[25]</xref>&#x000a0;Hyperferritinemia may herald the onset of iron overload.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref>&#x000a0;Magnetic resonance imaging (MRI) for hemosiderosis is useful in selected patients.</p>
      </sec>
      <sec id="article-28126.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Supportive therapy is important in chronic anemia. Folic acid supplementation is advocated for children. Pregnancy and hemolytic crises also warrant supplementation. These states are associated with increased folate demand. Blood transfusion ameliorates anemia. Decisions for transfusion must be justifiable. Good decisions are based on patient-specific presentations,&#x000a0;which may prevent iron overload in patients.<xref ref-type="bibr" rid="article-28126.r25">[25]</xref>&#x000a0;Increasing intervals between transfusion can reduce risk.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref></p>
        <p>Splenectomy is indicated for massive splenomegaly. This eliminates the risk of traumatic rupture. Severe anemia may also benefit from splenectomy. Total splenectomy is advocated in late childhood. Vaccination for encapsulated bacteria is required post-splenectomy.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Prophylactic antibiotics are also beneficial.<xref ref-type="bibr" rid="article-28126.r26">[26]</xref></p>
        <p>Hemosiderosis requires iron-chelation therapy with desferrioxamine. However, this should be stopped before pregnancy.<xref ref-type="bibr" rid="article-28126.r27">[27]</xref></p>
        <p>PKD patients can successfully navigate pregnancy. Pre-pregnancy surveillance for complications is essential. These include viral screening and maternal echocardiography. Appropriate counseling is required before screening tests.<xref ref-type="bibr" rid="article-28126.r28">[28]</xref>&#x000a0;Folate supplementation helps prevent fetal malformations. Transfusion should be reserved for symptomatic anemia. A hemoglobin level of less than 8 g/dL also requires transfusion.<xref ref-type="bibr" rid="article-28126.r27">[27]</xref><bold>&#x000a0;</bold>Management by hematologists and obstetricians is essential. Fetal surveillance is advisable for suspected growth restriction.<xref ref-type="bibr" rid="article-28126.r28">[28]</xref>&#x000a0;Preterm delivery occurs in 10% of cases.<xref ref-type="bibr" rid="article-28126.r25">[25]</xref></p>
      </sec>
      <sec id="article-28126.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of PKD include other causes of hemolytic anemia. Immune hemolysis and enzyme deficiencies are considerations. Antibody-mediated hemolysis occurs with blood-group incompatibility. Coombs' positivity characterizes blood-group incompatibility.<xref ref-type="bibr" rid="article-28126.r18">[18]</xref>&#x000a0;ABO and Rhesus incompatibility cause hydrops fetalis, whereas neonatal anemia with jaundice occurs in survivors. RBC membrane defects, such as hereditary spherocytosis, can also cause hemolysis. Spherocytes are easily evident on blood smears. Positive family history is usually found. Osmotic red cell lysis is also present. Flow cytometric diagnosis is the gold standard, and decreased ankyrin or spectrin expression is diagnostic.<xref ref-type="bibr" rid="article-28126.r29">[29]</xref></p>
        <p>Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive condition. It is the most common inherited enzymopathic cause of hemolytic anemia. Males are commonly affected. Rarely, females with lyonization are affected. African-American and Mediterranean heritage is common.<xref ref-type="bibr" rid="article-28126.r30">[30]</xref>&#x000a0;Hemolytic triggers include infections, medication, and oxidant stress. History and assaying enzyme activity aid diagnosis.<xref ref-type="bibr" rid="article-28126.r31">[31]</xref></p>
      </sec>
      <sec id="article-28126.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognostication in PKD is highly variable. Disease severity and early care modify outcomes. Severe anemia and hemosiderosis are unfavorable&#x000a0;and portend risk, particularly in pregnancy.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref><xref ref-type="bibr" rid="article-28126.r27">[27]</xref></p>
      </sec>
      <sec id="article-28126.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications may arise from hemolysis or therapy. Neonatal hyperbilirubinemia may be the first manifestation.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref> Hemolysis causes iron loading and hemosiderosis. Pigment gall stones commonly complicate PKD, and at least 30% of patients develop cholelithiasis.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Transfusions may also result in iron loading. Pre-transfusion screening reduces blood-borne viral transmission. Aplastic anemia from parvovirus B-19 infection is infrequent.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Extramedullary hemopoiesis may present with unusual masses. Paravertebral or intraabdominal masses require careful follow-up.<xref ref-type="bibr" rid="article-28126.r32">[32]</xref>&#x000a0;Pregnancy may be complicated by growth restriction.<xref ref-type="bibr" rid="article-28126.r33">[33]</xref></p>
      </sec>
      <sec id="article-28126.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Continuous patient education on infections is essential. Infection prevention may limit hemolytic episodes. Vaccination, prophylactic folate, and antibiotics are pertinent. Premarital education is essential in PKD prevention. Educating prospective couples helps in psychological preparation. Screening partners for carrier status is advisable.<xref ref-type="bibr" rid="article-28126.r27">[27]</xref>&#x000a0;Pre-pregnancy evaluation and advice are vital.</p>
      </sec>
      <sec id="article-28126.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Liver failure is unusual in PKD. However, a report has been made. A careful review of other causes is required. Remarkably, PKD may protect against malaria. Studies from Sub-Saharan Africa and Asia are supportive in this regard.<xref ref-type="bibr" rid="article-28126.r2">[2]</xref><xref ref-type="bibr" rid="article-28126.r34">[34]</xref></p>
      </sec>
      <sec id="article-28126.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PKD frequently poses a diagnostic dilemma. Causes of neonatal hyperbilirubinemia are myriad. Detecting PKD requires careful evaluation. Recently, PKD-specific patient-reported outcome measures were designed.&#x000a0;[Level 5]<xref ref-type="bibr" rid="article-28126.r1">[1]</xref>&#x000a0;This tool requires trials for widespread acceptability. Nonetheless, PKD-specific measurements are necessary. Interprofessional care assures the best outcomes. Hematologist and obstetrician-led pregnancy care are vital. Psychologists can provide patients critical support. Depression screening and prevention should be prioritized. Expert care will identify patients requiring support. Research into oral PK activators is on-going.<bold>&#x000a0;</bold>Gene therapy is possible but not recommended.<xref ref-type="bibr" rid="article-28126.r13">[13]</xref><bold>&#x000a0;</bold>Surgical management of massive splenomegaly may be required.<xref ref-type="bibr" rid="article-28126.r9">[9]</xref></p>
      </sec>
      <sec id="article-28126.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28126">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/pyruvate-kinase-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28126">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28126/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28126">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28126.s16">
        <title>References</title>
        <ref id="article-28126.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boscoe</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Piantedosi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Egan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klaassen</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Grace</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Storm</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments.</article-title>
            <source>Eur J Haematol</source>
            <year>2020</year>
            <month>May</month>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>427</fpage>
            <page-range>427-434</page-range>
            <pub-id pub-id-type="pmid">31880847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machado</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Manco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mendes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Salom&#x000e9;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sitoe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chibute</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Langa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amorim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>do Ros&#x000e1;rio</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Arez</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>e47071</fpage>
            <pub-id pub-id-type="pmid">23082140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Can&#x000e7;ado</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients.</article-title>
            <source>Hematol Transfus Cell Ther</source>
            <year>2018</year>
            <season>Jan-Mar</season>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-2</page-range>
            <pub-id pub-id-type="pmid">29519365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bianchi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fermo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glader</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kanno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barcellini</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Eber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoyer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kuter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Ma&#x000f1;u-Pereira</surname>
                <given-names>MDM</given-names>
              </name>
              <name>
                <surname>Kalfa</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Pissard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Segovia</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>van Beers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>van Wijk</surname>
                <given-names>R</given-names>
              </name>
              <collab>with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases</collab>
            </person-group>
            <article-title>Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.</article-title>
            <source>Am J Hematol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>149</fpage>
            <page-range>149-161</page-range>
            <pub-id pub-id-type="pmid">30358897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Secrest</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Storm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carrington</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Casso</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gilroy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pladson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Boscoe</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of pyruvate kinase deficiency: A systematic literature review.</article-title>
            <source>Eur J Haematol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>105</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-184</page-range>
            <pub-id pub-id-type="pmid">32279356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svidnicki</surname>
                <given-names>MCCM</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>JAA</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>APH</given-names>
              </name>
              <name>
                <surname>Magalh&#x000e3;es</surname>
                <given-names>IQ</given-names>
              </name>
              <name>
                <surname>Pinheiro</surname>
                <given-names>VRP</given-names>
              </name>
              <name>
                <surname>Brandalise</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>PAA</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>STO</given-names>
              </name>
            </person-group>
            <article-title>Novel mutations associated with pyruvate kinase deficiency in Brazil.</article-title>
            <source>Hematol Transfus Cell Ther</source>
            <year>2018</year>
            <season>Jan-Mar</season>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-11</page-range>
            <pub-id pub-id-type="pmid">29519373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaouani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kalai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chaouch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Douzi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Macedo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Darragi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Boudriga</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chaouachi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fitouri</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Van Wijk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Abbes</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.</article-title>
            <source>Int J Lab Hematol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-231</page-range>
            <pub-id pub-id-type="pmid">28133914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radosinska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vrbjar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia.</article-title>
            <source>Physiol Res</source>
            <year>2016</year>
            <month>Sep</month>
            <day>19</day>
            <volume>65 Suppl 1</volume>
            <fpage>S43</fpage>
            <page-range>S43-54</page-range>
            <pub-id pub-id-type="pmid">27643939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grace</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Zanella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neufeld</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Eber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yaish</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Glader</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte pyruvate kinase deficiency: 2015 status report.</article-title>
            <source>Am J Hematol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>9</issue>
            <fpage>825</fpage>
            <page-range>825-30</page-range>
            <pub-id pub-id-type="pmid">26087744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chartier</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paganelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bilodeau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Successful Liver Transplants for Liver Failure Associated With Pyruvate Kinase Deficiency.</article-title>
            <source>Pediatrics</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>141</volume>
            <issue>Suppl 5</issue>
            <fpage>S385</fpage>
            <page-range>S385-S389</page-range>
            <pub-id pub-id-type="pmid">29610156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hidden Antioxidative Functions of Reduced Nicotinamide Adenine Dinucleotide Coexisting with Hemoglobin.</article-title>
            <source>ACS Chem Biol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>21</day>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>1820</fpage>
            <page-range>1820-1829</page-range>
            <pub-id pub-id-type="pmid">28485916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhambhani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gadgeel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ravindranath</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Compound heterozygosity in <italic>PKLR</italic> gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency.</article-title>
            <source>Haematologica</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>104</volume>
            <issue>9</issue>
            <fpage>e428</fpage>
            <page-range>e428-e431</page-range>
            <pub-id pub-id-type="pmid">30948487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grace</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Mark Layton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barcellini</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>How we manage patients with pyruvate kinase deficiency.</article-title>
            <source>Br J Haematol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>184</volume>
            <issue>5</issue>
            <fpage>721</fpage>
            <page-range>721-734</page-range>
            <pub-id pub-id-type="pmid">30681718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lesmana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chonat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seu</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Heeney</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hopkin</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kalfa</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients.</article-title>
            <source>Hum Mutat</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-393</page-range>
            <pub-id pub-id-type="pmid">29288557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klei</surname>
                <given-names>TRL</given-names>
              </name>
              <name>
                <surname>Kheradmand Kia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Veldthuis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beuger</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Geissler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dehbozorgian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karimi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Bruggen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Zwieten</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.</article-title>
            <source>Eur J Haematol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>98</volume>
            <issue>6</issue>
            <fpage>584</fpage>
            <page-range>584-589</page-range>
            <pub-id pub-id-type="pmid">28295642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steiner</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte disorders in the perinatal period.</article-title>
            <source>Semin Perinatol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-61</page-range>
            <pub-id pub-id-type="pmid">17825683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christensen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Eggert</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Baer</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates from a polygamist community.</article-title>
            <source>J Perinatol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-6</page-range>
            <pub-id pub-id-type="pmid">20182430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nassin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lapping-Carr</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Anemia in the Neonate: The Differential Diagnosis and Treatment.</article-title>
            <source>Pediatr Ann</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>e159</fpage>
            <page-range>e159-63</page-range>
            <pub-id pub-id-type="pmid">26171704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meza</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Alonso-Ferrero</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quintana-Bustamante</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Valeri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garcia-Gomez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bueren</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Segovia</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.</article-title>
            <source>Mol Ther</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>2000</fpage>
            <page-range>2000-9</page-range>
            <pub-id pub-id-type="pmid">19755962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christensen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Yaish</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Nussenzveig</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Siblings with severe pyruvate kinase deficiency and a complex genotype.</article-title>
            <source>Am J Med Genet A</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>170</volume>
            <issue>9</issue>
            <fpage>2449</fpage>
            <page-range>2449-52</page-range>
            <pub-id pub-id-type="pmid">27354418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amzarul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vaish</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Physiological changes in hematological parameters during pregnancy.</article-title>
            <source>Indian J Hematol Blood Transfus</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>144</fpage>
            <page-range>144-6</page-range>
            <pub-id pub-id-type="pmid">23997449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vricella</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Emerging understanding and measurement of plasma volume expansion in pregnancy.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>106</volume>
            <issue>Suppl 6</issue>
            <fpage>1620S</fpage>
            <page-range>1620S-1625S</page-range>
            <pub-id pub-id-type="pmid">29070547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haley</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Congenital Hemolytic Anemia.</article-title>
            <source>Med Clin North Am</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>361</fpage>
            <page-range>361-374</page-range>
            <pub-id pub-id-type="pmid">28189176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>An</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features of Neonates with Hydrops Fetalis.</article-title>
            <source>Am J Perinatol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>13</issue>
            <fpage>1231</fpage>
            <page-range>1231-9</page-range>
            <pub-id pub-id-type="pmid">26070120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Beers</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>van Straaten</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Barcellini</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Eber</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Glader</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yaish</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Chonat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kwiatkowski</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rothman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neufeld</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Sheth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Despotovic</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kollmar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Posp&#x000ed;&#x00161;ilov&#x000e1;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Knoll</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pastore</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Ravindranath</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Wlodarski</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Holzhauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Breakey</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Verhovsek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kunz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McNaull</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bradeen</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Addonizio</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Sayegh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Grace</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.</article-title>
            <source>Haematologica</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>104</volume>
            <issue>2</issue>
            <fpage>e51</fpage>
            <page-range>e51-e53</page-range>
            <pub-id pub-id-type="pmid">30213831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cheshire</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bowley</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Postsplenectomy Prophylaxis: A Persistent Failure to Meet Standard?</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>ofw197</fpage>
            <pub-id pub-id-type="pmid">27975073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolan</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moohan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate kinase deficiency in pregnancy complicated by iron overload.</article-title>
            <source>BJOG</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>109</volume>
            <issue>7</issue>
            <fpage>844</fpage>
            <page-range>844-6</page-range>
            <pub-id pub-id-type="pmid">12135225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohamed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sivarajah</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chakravarti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A case of severe pyruvate kinase deficiency in a primigravida: successful outcome.</article-title>
            <source>Obstet Med</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-91</page-range>
            <pub-id pub-id-type="pmid">27757165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iolascon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Avvisati</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Piscopo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Hereditary spherocytosis.</article-title>
            <source>Transfus Clin Biol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>138</fpage>
            <page-range>138-42</page-range>
            <pub-id pub-id-type="pmid">20655264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bubp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matuszewski</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.</article-title>
            <source>P T</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>572</fpage>
            <page-range>572-4</page-range>
            <pub-id pub-id-type="pmid">26417175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satyagraha</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Sadhewa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elvira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Elyazar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Feriandika</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Antonjaya</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Oyong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Subekti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rozi</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Domingo</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Harahap</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>e0004457</fpage>
            <pub-id pub-id-type="pmid">26894297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaikh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bakalov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amjad</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Paravertebral Mass and Diffuse Lymphadenopathy in a Patient with Pyruvate Kinase Deficiency: Malignancy or Alternative Etiology?</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Jun</month>
            <day>06</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e4849</fpage>
            <pub-id pub-id-type="pmid">31410332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wax</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Pinette</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cartin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pyruvate kinase deficiency complicating pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2 Pt2</issue>
            <fpage>553</fpage>
            <page-range>553-5</page-range>
            <pub-id pub-id-type="pmid">17267892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28126.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Bruggen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gualtieri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iliescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Louicharoen Cheepsunthorn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mungkalasut</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trape</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Modiano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sirima</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Singhasivanon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lathrop</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakuntabhai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bureau</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Gros</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>e0144555</fpage>
            <pub-id pub-id-type="pmid">26658699</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
